Clinical Trial Update: Efficacy of Sildenafil in Preterm Preeclampsia [Phase 2, Phase 3]

View source ↗

Summary

The Phase 2/Phase 3 trial evaluating sildenafil for preterm preeclampsia has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Preeclampsia

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Preterm Preeclampsia | Phase 2, Phase 3 | Status: WITHDRAWN